Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:146498rdf:typepubmed:Citationlld:pubmed
pubmed-article:146498lifeskim:mentionsumls-concept:C0341628lld:lifeskim
pubmed-article:146498lifeskim:mentionsumls-concept:C0441472lld:lifeskim
pubmed-article:146498lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:146498pubmed:issue11alld:pubmed
pubmed-article:146498pubmed:dateCreated1978-3-10lld:pubmed
pubmed-article:146498pubmed:abstractTextThe acne-inducing effect of butyl 6alpha-fluoro-11beta-hydroxy-16alpha-methyl-3,20-dioxo-1,4-pregnadien-21-oate (fluocortin butylester, Vaspit) 0.75% was compared with that of hydrocortisone acetate 1.0% and diflucortolone valerate 0.1% in a model established by Plewig and Kligman. The steroid and the cream base uniformly used in all preparations were applied to the backs of 20 volunteers over 4 weeks. Dome-shaped red papules developed in the third week of occlusive treatment, and were counted in an area of 16 cm2 at the maximum of their development and graded according to a scale. The degree of papulation under diflucortolone valerate 0.1% was 2.15+/-0.75. No differences were observed between fluocortin butylester 0.75% (0.2+/-0.42), hydrocortisone acetate and the cream base (0.15+/-0.37).lld:pubmed
pubmed-article:146498pubmed:languagegerlld:pubmed
pubmed-article:146498pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:146498pubmed:citationSubsetIMlld:pubmed
pubmed-article:146498pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:146498pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:146498pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:146498pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:146498pubmed:statusMEDLINElld:pubmed
pubmed-article:146498pubmed:issn0004-4172lld:pubmed
pubmed-article:146498pubmed:authorpubmed-author:WendtHHlld:pubmed
pubmed-article:146498pubmed:issnTypePrintlld:pubmed
pubmed-article:146498pubmed:volume27lld:pubmed
pubmed-article:146498pubmed:ownerNLMlld:pubmed
pubmed-article:146498pubmed:authorsCompleteYlld:pubmed
pubmed-article:146498pubmed:pagination2245-6lld:pubmed
pubmed-article:146498pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:146498pubmed:meshHeadingpubmed-meshheading:146498-H...lld:pubmed
pubmed-article:146498pubmed:meshHeadingpubmed-meshheading:146498-A...lld:pubmed
pubmed-article:146498pubmed:meshHeadingpubmed-meshheading:146498-M...lld:pubmed
pubmed-article:146498pubmed:meshHeadingpubmed-meshheading:146498-A...lld:pubmed
pubmed-article:146498pubmed:meshHeadingpubmed-meshheading:146498-H...lld:pubmed
pubmed-article:146498pubmed:meshHeadingpubmed-meshheading:146498-A...lld:pubmed
pubmed-article:146498pubmed:meshHeadingpubmed-meshheading:146498-A...lld:pubmed
pubmed-article:146498pubmed:meshHeadingpubmed-meshheading:146498-P...lld:pubmed
pubmed-article:146498pubmed:meshHeadingpubmed-meshheading:146498-F...lld:pubmed
pubmed-article:146498pubmed:year1977lld:pubmed
pubmed-article:146498pubmed:articleTitle[Clinico-pharmacological studies on the acne-inducing action of fluocortin butylester (author's transl)].lld:pubmed
pubmed-article:146498pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:146498pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:146498pubmed:publicationTypeEnglish Abstractlld:pubmed